The Anastomosis Devices market will grow at highest pace owing to rising geriatric population.

Anastomosis devices are medical devices used to join together or reconnect tubular structures of the body, such as blood vessels or intestinal or digestive tract segments, after all or part of a tubular structure has been removed due to cancer or other diseases. Anastomosis devices allow a join to be made that maintains the integrity of the tubular structure and minimizes or prevents leaking. The need for anastomosis devices is increasing due to rising number of surgical procedures such as colorectal surgery, coronary artery bypass graft, gastrectomy and other cancer surgeries which require reconnection of tubular structures. The Global Anastomosis Devices Market is estimated to be valued at US$ 25.81 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Anastomosis Devices Market Growth are AGSCO Corporation, Carborundum Universal Ltd., Entegris Inc. ESD-SIC b.v., ESK-SIC GmbH, Gaddis Engineered Materials, Grindwell Norton Ltd., Norstel AB, Saint-Gobain Ceramics Materials GmbH, and Snam Abrasives Pvt. Ltd. These players are focusing on developing advanced anastomosis products with minimal invasive techniques.

The demand for anastomosis devices is growing significantly due to rise in geriatric population worldwide which is more prone to various chronic diseases such as cancer that require surgical procedures. According to WHO, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050.

Technological advancements are also fueling the growth of anastomosis devices market. Major players are developing innovative anastomosis products using advanced materials and minimal invasive techniques. For instance, new bioabsorbable anastomosis devices that do not require removal are developed to reduce complications.

Market Trends

Growing preference for minimally invasive surgeries: Minimally invasive surgeries create very small incisions as compared to traditional open surgeries. This reduces pain, blood loss, recovery time and risk of surgical site infections. Thus, anastomosis devices compatible for minimally invasive techniques are gaining more acceptance.

Increasing adoption of bioabsorbable anastomosis devices: Temporary anastomosis devices used currently need to be removed after serving the purpose of joining tubular structures. However, these removal procedures carry risk of complications. To address this, major players are developing totally bioabsorbable anastomosis devices that dissolve once body completes healing process.

Market Opportunities

Emerging economies in Asia Pacific: Countries like India, China and South Korea are witnessing rapid economic growth and development of healthcare infrastructure which is expected to drive the demand for sophisticated anastomosis devices in these regions.

Product innovation to reduce complications: Further innovations in anastomosis device designs, biomaterials and techniques can help reduce anastomotic leakage, bleeding and other complications. This will boost the market potential.

Impact of COVID-19 on Anastomosis Devices Market
The COVID-19 pandemic has significantly impacted the growth of anastomosis devices market. During the initial outbreak, elective surgeries were postponed to avoid infection spread and focus on COVID care. This resulted in decline in demand for anastomosis devices in 2020. However, with resumption of elective surgeries in 2021, the market is recovering gradually.

The key challenge being faced is maintaining a balance between attending to COVID and non-COVID patients. Healthcare systems are under tremendous pressure. Procedures requiring anastomosis devices are being prioritized based on medical necessity. Telemedicine is being leveraged for post-operative follow ups to minimize physical visits.

Supply chain disruptions were also reported during lockdowns due to restrictions on transportation. Manufacturers faced issues in sourcing raw materials. However, with relaxations in restrictions and vaccination drives, supply chains are getting restored slowly.

Going forward, demand is expected to increase steadily as backlogs of postponed surgeries are addressed. Companies are focusing on ensuring adequate inventory levels and developing single-use devices to minimize infection risk. Telehealth will continue complementing conventional treatment. If COVID surge remains under control, the market is projected to get back on the pre-pandemic growth trajectory by 2023.

Geographical regions with high concentration of Anastomosis Devices market in terms of value
North America holds the largest share of the anastomosis devices market in terms of value, owing to rising prevalence of target diseases, availability of advanced healthcare facilities, and favorable reimbursement structure. Within the region, the US accounts for the major revenue share.

Europe is the second largest regional market supported by growing elderly population undergoing various surgical interventions. Advancing medical technology and initiatives to modernize healthcare infrastructure are boosting the European market.

Asia Pacific is emerging as the fastest growing geographical region for anastomosis devices market. Improving access to healthcare, increasing healthcare expenditure, and expanding medical tourism industry are some key factors driving the APAC regional market.

Fastest growing geographical region for Anastomosis Devices market
Asia Pacific region is projected to be the fastest growing geographical market for anastomosis devices during the forecast period from 2024 to 2031. This can be attributed to the following factors:

- Rapidly aging population and increasing life expectancy in countries like China and India are leading to growth in target patient pool undergoing surgical procedures requiring anastomosis devices.

- Surging healthcare expenditure by governments aiming to strengthen public healthcare systems across APAC economies.

- Rising medical tourism in Thailand, Singapore, and Malaysia is attracting patients from other regions for surgical treatments.

- Growing adoption of advanced medical technologies by both private and public healthcare facilities to deliver enhanced clinical outcomes.

- Expanding health insurance coverage and wider access to essential medical services driving the uptake of anastomosis devices across Asia Pacific region.

Get more insights on Anastomosis Devices Market